Bardonnet, Pierre-Louis
Niu, Zhigao https://orcid.org/0000-0002-3512-4885
Pessi, Jenni
Kazakou, Maria
Raptis, Konstantinos
McCabe, Reece
Toftlev, Anders
Rebollo, René
Wang, Zhuoran
Fan, Li
Mortensen, Nicolai Rytter
Bardtrum, Lars
Andersson, Vincent
Wahlund, Per-Olof
Norrman, Mathias
Benie, Andrew James
Wu, Jian Xiong
Sauter, Max
Zara, Damiano La
Christophersen, Philip
Sassene, Philip Jonas
Article History
Received: 28 July 2025
Accepted: 12 September 2025
First Online: 23 September 2025
Declarations
:
: The clinical study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines, and all participants provided informed consent before any trial-related activities. The protocol and informed consent forms were reviewed and approved by appropriate health authorities as well as institutional review boards according to local regulation. The study was registered at ClinicalTrials.gov (identifier: NCT05333107).All procedures involving animals were approved by and performed in accordance with the Committee on Animal Care at the Novo Nordisk Environment and Bioethics Committee.
: The manuscript has been approved by all named authors for publication.
: All authors are, or were at the time of conducting the studies, employees of Novo Nordisk A/S. All authors involved in this work declare no conflict of interest.